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Abstract
Background: Cigarette smoking is a leading cause of preventable death and a significant cause of lung
cancer and chronic obstructive pulmonary disease. Prior studies have demonstrated that smoking creates
a field of molecular injury throughout the airway epithelium exposed to cigarette smoke. We have
previously characterized gene expression in the bronchial epithelium of never smokers and identified the
gene expression changes that occur in the mainstem bronchus in response to smoking. In this study, we
explored relationships in whole-genome gene expression between extrathorcic (buccal and nasal) and
intrathoracic (bronchial) epithelium in healthy current and never smokers.
Results: Using genes that have been previously defined as being expressed in the bronchial airway of never
smokers (the "normal airway transcriptome"), we found that bronchial and nasal epithelium from non-
smokers were most similar in gene expression when compared to other epithelial and nonepithelial
tissues, with several antioxidant, detoxification, and structural genes being highly expressed in both the
bronchus and nose. Principle component analysis of previously defined smoking-induced genes from the
bronchus suggested that smoking had a similar effect on gene expression in nasal epithelium. Gene set
enrichment analysis demonstrated that this set of genes was also highly enriched among the genes most
altered by smoking in both nasal and buccal epithelial samples. The expression of several detoxification
genes was commonly altered by smoking in all three respiratory epithelial tissues, suggesting a common
airway-wide response to tobacco exposure.
Conclusion: Our findings support a relationship between gene expression in extra- and intrathoracic
airway epithelial cells and extend the concept of a smoking-induced field of injury to epithelial cells that
line the mouth and nose. This relationship could potentially be utilized to develop a non-invasive
biomarker for tobacco exposure as well as a non-invasive screening or diagnostic tool providing
information about individual susceptibility to smoking-induced lung diseases.
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Background
Approximately 1.3 billion people smoke cigarettes world-
wide contributing to almost 5 million preventable deaths
per year [1]. Smoking is a significant risk factor for lung
cancer, the leading cause of cancer-related death in the
United States, and chronic obstructive pulmonary disease
(COPD), the fourth leading cause of death overall.
Approximately 90% of lung cancer can be attributed to
cigarette smoking, with 10–15% of smokers developing
this disease [2]. Despite the well-established causal role of
cigarette smoke in lung cancer and COPD, the molecular
mechanisms by which these diseases arise are poorly
understood and there are no tools currently available to
determine individual variations in response to smoking.
Previous work has demonstrated that cigarette smoke cre-
ates a field of injury in epithelial cells that line the respira-
tory tract. Several studies have shown that histologically
normal large airway epithelial cells of current and former
smokers with and without lung cancer display allelic loss
[3,4], p53 mutations [5], changes in promoter methyla-
tion [6] and increased telomerase activity [7]. Using epi-
thelial cells collected from brushings of the mainstem
bronchus at the time of bronchoscopy, we have previously
characterized the effect of smoking on the bronchial air-
way epithelial transcriptome and found that smoking
induces expression of genes involved in regulation of oxi-
dant stress, xenobiotic metabolism, and oncogenesis
while suppressing those involved in regulation of inflam-
mation and tumor suppression [8]. In addition, we
recently developed a profile of bronchial airway gene
expression that can distinguish smokers with and without
lung cancer and serve as an early diagnostic biomarker for
disease [9]. Although these studies of intrathoracic airway
epithelium obtained via bronchoscopy have successfully
identified candidate biomarkers of smoking-related lung
damage, there remains significant impetus to develop
biomarkers of these events from tissue obtained via less
invasive collection procedures. Use of material from a less
invasive collection site would allow for the use of larger
cohorts for developing and validating biomarkers of
tobacco exposure and susceptibility to tobacco-related
disease.
Oral and nasal epithelium are attractive candidate tissues
for assaying the host response to tobacco-smoke exposure
since, like the bronchial airway, they are exposed to high
concentrations of compounds contained within cigarette
smoke. We have previously shown that it is feasible to
obtain sufficient RNA from buccal mucosa for gene
expression analysis [10] despite the high level of RNAses
in saliva [11,12]. Few studies have characterized global
gene expression in either buccal or nasal mucosa, and
none have attempted to establish a link between extra-
and intrathoracic airway gene expression changes that
occur with smoking. Smith et al. used brush biopsies of
buccal mucosa from smokers and non-smokers to obtain
RNA for cDNA microarrays and found approximately 100
genes that could distinguish the two groups in training
and test sets [13]. While this study provided evidence that
buccal gene expression changes with smoking, it did not
address the relationship between the gene expression
response to tobacco smoke in the mouth and bronchial
airways. Using real-time PCR, Spivack et al. found a qual-
itative relationship between matched buccal mucosa and
laser-dissected lung epithelial cell samples across nine car-
cinogen or oxidant-metabolizing genes in 11 subjects
being evaluated for lung cancer [14]. Smoking has also
been implicated in the formation of DNA adducts in nasal
mucosa [15], and the correlation between adduct forma-
tion in bronchial and nasal epithelium has been previ-
ously reported [16]. While global gene expression
profiling of nasal epithelial brushing has been recently
reported in children with asthma [17] and cystic fibrosis
[18], there are no studies that address the effects of smok-
ing on global gene expression in nasal epithelium or
explore relationships in gene expression between epithe-
lial cell types throughout the respiratory tract in response
to cigarette smoke.
In this study, we examined relationships in gene expres-
sion between bronchial, nasal, and buccal epithelial cells
in current and never smokers. Using previously published
microarray data, we evaluated the relationship of buccal,
nasal, and bronchial epithelial gene expression in never
smokers compared to other epithelial and non-epithelial
tissues. We subsequently compared gene expression con-
sequences of smoking in bronchial epithelial cells to
those seen in buccal and nasal epithelium. Our results
suggest that gene expression changes occurring in bron-
chial epithelium in response to cigarette smoke are
reflected in buccal and nasal epithelium. As a result, we
believe that gene expression biomarkers of host response
tobacco exposure may ultimately either be applied to or
derived from these tissues.
Results
Study Population
Twenty five subjects were recruited for nasal and buccal
mucosa microarray studies and 14 additional subjects
were recruited for real competitive PCR validation experi-
ments on buccal mucosa samples. Demographic data for
the microarray study group is presented in Table 1. Demo-
graphic data for the real competitive PCR validation group
is presented in Additional File 4.BMC Genomics 2008, 9:259 http://www.biomedcentral.com/1471-2164/9/259
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Relationship of gene expression profiles between 
intrathoracic and extrathoracic airway epithelium in never 
smokers
In order to explore gene-expression relationships between
different airway epithelial tissues in healthy non smokers,
principal component analysis (PCA) of the normal airway
transcriptome [8] was performed across 11 different non-
diseased tissue datasets (Figure 1). Nine microarray data-
sets containing normal tissue samples from previously
published studies were collected from the Gene Expres-
sion Omnibus (GEO). These datasets were analyzed along
with the 8 normal nasal epithelial and 5 normal buccal
mucosa samples from this study. A detailed list of the dif-
ferent datasets used is shown in Table 2. Seven of the
eleven datasets analyzed came from tissues of epithelial
origin, including an additional set of normal nasal epithe-
lial samples from a separate study [18]. The co-localiza-
tion of bronchial and nasal samples in a graph of the first
two principal components suggests a relationship
between these two tissues when compared to other epi-
thelial tissues analyzed. Buccal mucosa samples did not
group with either bronchial or nasal epithelial samples.
Table 1: Patient demographics
Buccal Microarray (n = 10) Nasal Microarray (n = 15)
Smokers n = 5 Never n = 5 P-Value Smokers n = 7 Never n = 8 P-Value
Sex 1 M, 4 F 2 M, 3 F p = 0.42 6 M, 1 F 6 M, 2 F p = 0.58
Age 36 (+/- 8) 31 (+/- 9) p = 0.36 47 (+/- 12) 43 (+/- 18) p = 0.46
Race 3 CAU, 2 AFA 2 CAU, 3 AFA p = 0.40 3 CAU, 3 AFA, 1 HIS 5 CAU, 2 AFA, 1 HIS p = 0.73
Demographic data for patient samples used in the microarray studies (n = 25). Clinical information including sex, age, and race are included (CAU – 
Caucasian, AFA – African American, HIS – Hispanic). Statistical comparisons were performed between smokers vs. nonsmokers within each tissue 
type. P-values for sex and race were determined by Fisher exact test.
Principal component analysis of 2382 genes from the normal bronchial airway transcriptome across 11 tissue datasets Figure 1
Principal component analysis of 2382 genes from the normal bronchial airway transcriptome across 11 tissue 
datasets. Principal component analysis (PCA) of the expression of 2382 genes from the never-smoker bronchial-airway tran-
scriptome [8] in samples from 11 different tissue datasets. Bronchial and nasal epithelial samples group together along the first 
and second principal components (representing 66% and 12% of the variance in gene expression respectively) based on the 
expression of these genes. Tissue types are color-coded.
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To determine the similarities in the expression of func-
tional categories of genes that are over represented in the
never smoker bronchial airway transcriptome [8] and are
likely to play a role in mediating the response to tobacco
smoke exposure, we examined the expression of fifty-nine
genes involved in detoxification (e.g. cytochrome P450
family, glutathiones, aldehyde dehydrogenases), as well
as important epithelial cell structural components (e.g.
mucins, dyneins, microtubule associated genes) across the
11 normal tissue datasets (Figure 2). Bronchial and nasal
epithelial samples clustered together based on the expres-
sion of these 59 genes, with many being expressed at
higher levels in these two tissues, including genes belong-
ing to the dynein, cytochrome P450, and aldehyde dehy-
drogenase gene families. Buccal mucosa samples clustered
with lung tissue, with specific keratin genes being highly
expressed in both tissues. While some keratins were
expressed specifically in skin and esophageal epithelium,
other keratins, such as KRT7, KRT8, KRT18, and KRT19
were expressed primarily in bronchial and nasal samples.
The same pattern was seen with mucin genes, with MUC4,
MUC5AC, and MUC16 being expressed primarily in the
bronchus and nose, while MUC1 was expressed in other
epithelial tissues. Glutathione genes were expressed
highly in bronchial and nasal epithelial tissue as well as
other tissues.
Effects of cigarette smoke on intrathoracic and 
extrathoracic epithelial gene expression
To examine the similarities of tobacco-induced differen-
tial gene expression between the bronchus and the buccal
and nasal epithelium, gene expression profiles from buc-
cal (n = 10) and nasal (n = 15) epithelial samples col-
lected from current and never smokers were analyzed
together with previously published bronchial epithelial
samples collected from current and never smokers (n =
57) [8]. Three hundred and sixty-one genes differentially
expressed (p < 0.001) between current and never smokers
in bronchial epithelium [8] distinguish the bronchial and
nasal epithelial samples by smoking status using principal
component analysis, with separation among buccal
mucosa samples being less clear (Figure 3). These results
suggest that the gene-expression response to smoking is
similar in bronchial and nasal epithelium.
Gene set enrichment analysis (GSEA) was performed (see
Additional File 1) to determine which of the genes that are
affected by smoking in bronchial epithelium are among
the most highly perturbed by smoking in nasal and buccal
epithelium. Genes up-regulated in the airway in response
to smoking are significantly enriched among the genes
most up-regulated by smoking in buccal mucosa (p <
0.001), with 74 genes composing the "leading edge sub-
set" (Figure 4A). The leading edge consists of the subset of
bronchial smoking-related genes that are most differen-
tially expressed in response to smoking in buccal mucosa.
Bronchial smoking-related genes are also significantly
enriched among the genes that are differentially expressed
in nasal epithelium in response to smoking (p < 0.001),
with 120 genes comprising the leading edge subset (Figure
4B). Forty-five genes are common to both leading edges
(Figure 5A, Additional File 5), suggesting that these genes
represent common tobacco-induced changes that occur in
all airway epithelial cells that are exposed to tobacco
smoke. Genes with oxidoreductase and electron trans-
porter activity are enriched among these commonly
smoking-induced genes (p < 0.0001). Genes from the
mainstem bronchus that are down-regulated in response
to smoking were not significantly enriched among buccal
mucosa genes most altered by smoking. However, down-
regulated bronchial genes are enriched among genes most
down-regulated in response to smoking in the nasal epi-
thelium (p < 0.001), yielding a leading edge subset of 50
genes (Figure 5B). Genes involved in cell motility, cell
migration, development, and localization of cellular com-
plexes are enriched among these smoking-repressed genes
(p < 0.001). In addition, we performed GSEA using the
top 100 up- or 100 down-regulated-by-smoking genes
Table 2: Description of all microarray datasets analyzed in this study.
Category Tissue # Samples Platform GEO reference Sample Description
Epithelial Mouth 5 U133A GSE8987 5 never smokers
Epithelial Bronch 23 U133A GSE994 23 never smokers
Epithelial Nose 8 U133A+2.0 GSE8987 8 never smokers
Epithelial Nose 11 U133A GSE2395 11 normal nasal epithelial samples; from cystic fibrosis study
Epithelial Lung 14 U133A GSE1650 no/mild emphysema patients; from COPD study
Epithelial Skin 5 U133A GSE5667 normal skin tissue
Epithelial Esophagus 8U 1 3 3 A G S E 1 4 2 0 n o r m a l   esophageal epithelium
Mostly epithelial Kidney 8 U133+2.0 GSE3526 4 kidney cortex, 4 kidney medulla (post-mortem)
non epithelial Bone marrow 5 U133+2.0 GSE3526 5 bone marrow (post-mortem)
non epithelial Heart 5 U133A GSE2240 left ventricular myocardium, non-failing
non epithelial Brain 11 U133A GSE5389 postmortem orbitofrontal cortex
Microarray datasets from 9 studies obtained from GEO, as well as the 2 datasets from this study are listed. Tissue type, total sample numbers, 
microarray platform, GEO accession number, and a brief description of each dataset are included.BMC Genomics 2008, 9:259 http://www.biomedcentral.com/1471-2164/9/259
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from buccal and nasal epithelium and found that genes
up-regulated in these tissues are enriched among the
genes that are most perturbed by smoking in bronchial
epithelium (see Additional File 1).
Validation of buccal mucosa changes using real 
competitive PCR
Three genes from the buccal mucosa leading-edge subset
were chosen for validation using real competitive PCR
[19] (see Additional File 1) in an independent set of buc-
cal epithelial samples obtained from 14 subjects (7 smok-
ers, 7 never-smokers). Using a MALDI TOF mass
spectrometry platform, gene expression analysis showed
that all three genes (CEACAM5, CYP4F11, S100P) were
more highly expressed in the oral epithelium of smokers
compared with non-smokers, consistent with the microar-
ray findings (Additional File 6).
Discussion
We have studied global gene expression in bronchial,
nasal, and buccal epithelial cells in never and current
smokers. Our findings suggest that similar functional cat-
egories of genes are expressed in nasal and bronchial epi-
thelial cells of healthy never smokers. We have shown that
there are similarities between the effect of smoking on
bronchial epithelial gene expression and the gene expres-
sion response to smoking in buccal and nasal epithelium.
This implies the potential to study disease-relevant
Hierarchical clustering of 59 genes representing functional categories over-represented in the normal bronchial airway tran- scriptome Figure 2
Hierarchical clustering of 59 genes representing functional categories over-represented in the normal bron-
chial airway transcriptome. Supervised hierarchical clustering of the expression of 59 probesets representing genes in the 
mucin, dynein/microtubule, cytochrome P450, glutathione, aldehyde dehydrogenase, and keratin functional categories across 
samples from 11 tissue datasets. Nasal and bronchial epithelial samples cluster together based on similar expression patterns 
across these groups of genes (high expression = red, average expression = white, low expression = blue).
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responses to tobacco smoke in any of these tissues. This
represents a significant advantage as buccal and nasal
mucosa can be readily collected from large study cohorts
as a result of their ability to be collected non-invasively.
Given the burden of smoking-related disease, there is a
need for non-invasive biomarkers of the individual-level
variability in host responses to cigarette smoke.
The similar pattern of gene expression in bronchial and
nasal epithelial cells of never smokers suggests a shared
architecture and function. The nasal passage and bron-
chus are both lined with ciliated pseudostratified colum-
nar epithelial cells, and some of the functions of genes
that are highly expressed in both nasal and bronchial epi-
thelial cells are likely due to this common cellular archi-
tecture. For example, cilia-related genes such as DNAH7,
DNAH9, and DNAI2 were highly expressed in both bron-
chial and nasal airway epithelium. Consistent with this
finding, previous studies have shown that normal ciliated
airway epithelial cells express these genes [20-22]. Other
dynein light chain genes such as DYNLRB1 which have
been characterized in other non-epithelial tissues [23]
were found to be specifically expressed in bronchial epi-
thelial cells, while dynein light chain genes such as
DYNLL1 shared relatively high expression specifically in
nasal epithelium as well as non-epithelial tissues. Many
genes involved in host defense are also expressed at high
levels in extra- and intrathoracic airway epithelial cells.
Glutathione expression has been previously well charac-
terized in bronchial epithelium as well as in the lung [24].
Our data show high expression of glutathiones such as
GSTM1 in bronchial, nasal, and buccal epithelium relative
to other non-airway epithelial cells. We also observed
high expression of mucins such as MUC1, MUC4, and
MUC5AC in bronchial and nasal epithelium and some-
what lower expression of MUC1 in buccal mucosa and
lung tissue. Expression of these genes has been well docu-
mented in respiratory tract epithelium [25-29]. We found
the genes belonging to the cytochrome P450 family and
several aldehyde dehydrogenase genes [30] are highly
expressed the bronchial and nasal epithelium. Cyto-
chrome P450 genes have previously been shown to be
expressed highly in both bronchial epithelial cells [31-33]
and nasal mucosa [34]. Our global analysis of gene-
expression of the airway epithelium of healthy never
smokers recapitulates gene expression patterns previously
observed within these tissue types, thereby lending sup-
port to the similarities and differences between tissues
that are suggested by our analysis of gene expression in the
normal intrathoracic airway transcriptome.
Principal component analysis of 361 differentially expressed bronchial epithelial genes across bronchial, nasal, and buccal  mucosa samples Figure 3
Principal component analysis of 361 differentially expressed bronchial epithelial genes across bronchial, nasal, 
and buccal mucosa samples. PCA of the expression of genes that are perturbed by smoking in the bronchial airway in sam-
ples of bronchial, nasal, and buccal epithelium from smokers and non-smokers. Bronchial and nasal epithelial samples separate 
according to smoking status, while the separation of buccal mucosa samples by smoking status is less pronounced. The first 
two principal components account for 27% and 9% of the total variance in gene expression respectively.
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Smoking altered the expression of a set of genes in bron-
chial epithelial cells which were also commonly altered in
nasal and buccal epithelial cells. Gene set enrichment
analysis of 361 smoking-induced bronchial genes yielded
a subset of genes that were among the most up-regulated
by smoking in the mouth (74 leading edge genes), as well
as a subset of genes that are among the most up-regulated
by smoking in the nose (120 leading edge genes). Forty-
five genes were common to both sets, representing genes
that share similar smoking-related expression patterns
across all three airway epithelial tissues. This analysis
demonstrates a common response to cigarette smoke
exposure in cells lining the respiratory tract. Within this
set are multiple genes involved in each of several processes
including detoxification, cell cycle progression and cell
adhesion. In addition, a common set of genes was down-
regulated in response to smoking in both bronchial and
nasal epithelium.
Several CYP450 genes were commonly up-regulated by
smoking in only the nose and airway including CYP1A1
and CYP1B1, as well as cell cycle (CCNG2, RAB2) and cell
adhesion genes (CEACAM5, CEACAM6). The presence of
mutations in CYP1A1 in nasal and bronchial mucosa has
been shown previously in smokers [16], and cytochrome
P450 genes are known to be involved in xenobiotic
metabolism in bronchial mucosa [35]. Exposure of alveo-
lar epithelial cells to environmental toxins has been
shown to promote cell cycle progression [36], which
could explain the increased expression of cell cycle genes
in the nasal epithelial cells of smokers. Glutathiones such
as GPX2 were up-regulated in both bronchial and buccal
epithelial cells. Aldo-keto reducatse genes which are acti-
vated in response to cigarette smoke in human oral squa-
mous cell lines [37], are also up-regulated in both
bronchial and buccal epithelial samples. Oxidoreductase
genes are up-regulated in all three airway epithelium
including other CYP450 genes (CYP4F3, CYP4F11), alde-
Enrichment of differentially expressed bronchial epithelial genes among smoking-induced genes in the buccal mucosa or nasal  epithelium Figure 4
Enrichment of differentially expressed bronchial epithelial genes among smoking-induced genes in the buccal 
mucosa or nasal epithelium. Results from gene set enrichment analysis (GSEA) shows that 361 genes induced in bronchial 
epithelial cells from smokers are significantly skewed toward being among the genes most induced in buccal (A) or nasal (B) 
epithelial samples in response to smoking (p < 0.001). There are 74 genes that comprise the buccal "leading edge subset" and 
120 genes that comprise the nasal "leading edge subset". These two analyses suggest that genes induced by smoking in the 
bronchus show a similar pattern of differential expression in buccal and nasal epithelium.
A BBMC Genomics 2008, 9:259 http://www.biomedcentral.com/1471-2164/9/259
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hyde dehydrogenases (ALDH3A1), and aldo-keto reduct-
ases (AKR1B1), suggesting that smoking activates
common detoxification pathways in exposed airway epi-
thelial cells.
Gene set enrichment analysis also identified genes that are
among the most down-regulated in both nasal and bron-
chial epithelium in response to tobacco exposure. SLIT2,
which is a known tumor suppressor that is down-regu-
lated in lung cancer [38,39] is among these genes. We
found HNMT, which is expressed highly in both bron-
chial and nasal mucosa [40,41], and has been shown to be
down-regulated with smoking in other mucosal cells [42],
to be down regulated in smoking in bronchial and nasal
epithelium. The genes that are among the most down reg-
ulated by smoking in both bronchial and nasal epithe-
lium were enriched for those with functions in cellular
localization, migration, and motility genes. These data
suggest that smoking results in the down-regulation of
structural genes in these tissues.
Based on the data presented here, we suggest that aspects
of the bronchial gene expression response to smoking are
also changed by smoking in nasal epithelium, with certain
of these genes also being perturbed by smoking in buccal
mucosa. This suggests that there are common features in
Hierarchical clustering of genes commonly perturbed by smoking across intra- and extrathoracic airway epithelium Figure 5
Hierarchical clustering of genes commonly perturbed by smoking across intra- and extrathoracic airway epi-
thelium. A. Supervised hierarchical clustering of the expression of 45 genes induced by smoking in the bronchial airway that 
are present in both the nasal and buccal "leading edge subsets" in samples from smokers and non-smokers. These represent 
genes up-regulated by smoking in bronchial, nasal, and buccal epithelium. B. Supervised hierarchical clustering of the expression 
of 50 genes repressed by smoking in the bronchial airway that are present in the nasal "leading edge subset" in samples from 
smokers and nonsmokers. (High expression = red, average expression = white, low expression = blue).
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the field of injury caused by cigarette smoke throughout
the airway. Our data also suggest that the gene-expression
consequences of smoking are less pronounced in buccal
mucosa (see Figure 3). This could be due to a number of
factors: 1) the effects of smoking on buccal mucosa might
indeed be less pronounced; 2) there may be more inter-
subject variability in buccal mucosa gene expression; 3)
the partial degradation of the RNA in the buccal mucosa
samples may contribute to variability in gene expression
estimates. Due to the high concentration of RNAses found
in saliva, RNA obtained from buccal epithelial cells was
subject to degradation, and relatively small amounts of
RNA were extracted from these cells. This required us to
pool samples collected from the same individual serially
over several weeks. Previous studies report similar issues
with salivary RNA run on microarrays [43]. Consistent
with the low yield of partially degraded RNA from buccal
samples, we detected sequence-specific hybridization
intensity for fewer probesets in the buccal samples than in
the nasal or bronchial samples. Despite these technical
limitations, there was considerable overlap between genes
that are among the most altered in response to smoking in
the nose and bronchus and those that are most differen-
tially expressed in the mouth based on the overlap
between the leading edge subsets from gene set enrich-
ment analysis. Differential expression of several genes
seen to be induced by smoking in buccal mucosa was val-
idated in buccal mucosa samples from independent vol-
unteers using real competitive PCR. Taken together, these
findings indicate that gene expression is perturbed by
smoking in buccal mucosa and suggest that techniques for
assaying gene expression in the context of partially
degraded RNA will facilitate further studies to determine
if buccal-mucosa specific factors contribute to the appar-
ent differences in the magnitude of the smoking response
of buccal mucosa relative to that seen in other airway epi-
thelia.
Conclusion
This study highlights the relationships between gene
expression profiles in epithelial cells that line the intra-
and extra-thoracic airway and identifies a common set of
genes that are induced by tobacco smoke in buccal, nasal
and bronchial epithelium, supporting the concept that
smoking induces a common field of injury throughout
the airway. These similarities suggest that easily collected
buccal and nasal epithelium can be used to measure an
individual's physiologic response to tobacco smoke.
Methods
Study Population
We recruited current and never smoker volunteers from
Boston Medical Center for buccal (n = 11) and nasal (n =
15) microarray studies, and subsequent buccal epithelial
samples for real competitive PCR validation using mass
spectrometry (n = 14). For each volunteer, a detailed
smoking history was obtained including number of pack-
years, number of packs per day, age started, and environ-
mental tobacco exposure. Current smokers in each group
had smoked at least 10 cigarettes per day in the past
month, with at least a cumulative smoking history of 10
pack-years. Non-smoking volunteers with significant
environmental cigarette exposure and subjects with respi-
ratory symptoms, known respiratory, nasal or oral dis-
eases, or regular use of inhaled medications were
excluded. The study was approved by the Institutional
Review Board of Boston Medical Center, and all subjects
provided written informed consent.
Buccal epithelial cell collection
Buccal epithelial cells were collected from 25 study partic-
ipants as previously reported [10]. Briefly, we used a non-
invasive method for obtaining small amounts of RNA
from the mouth using a concave plastic tool with serrated
edges. Using gentle pressure, the serrated edge was scraped
5 times against the buccal mucosa on the inside left cheek
and placed immediately into 1 mL of RNA Later (Qiagen,
Valencia, CA). The procedure was repeated for the inside
right cheek and the cellular material was combined into
one tube. After storage at room temperature for up to 24
hours, total RNA was isolated from the cell pellet using
TRIzol reagent (Invitrogen, Carlsbad, CA) according to the
manufacturer's protocol. The integrity of the RNA was
assessed on a denaturing agarose gel. Epithelial cell con-
tent on a representative set of samples was quantified by
cytocentrifugation at 700 × g (Cytospin, ThermoShandon,
Pittsburgh, PA) of the cell pellet and staining with a cytok-
eratin antibody (Signet, Dedham, MA). Using this proto-
col, we were able to obtain an average of 1823 ng +/- 1243
ng of total RNA per collection. Buccal epithelial cells were
collected serially over 6 weeks in order to obtain a mini-
mum of 8 ug of RNA per subject for microarray analysis.
For the 14 subjects included in the real competitive PCR
validation, a single collection yielded sufficient RNA given
the reduced requirement for starting material.
Nasal epithelial cell collection
Using a nasal speculum (Bionix Medical Technologies,
Toledo, OH), epithelial cells were collected from the right
inferior turbinate with a standard cytology brush (Medical
Packaging Company, Camarillo, CA). Brushings were
immediately placed in RNA lysis buffer and snap frozen in
liquid nitrogen. Samples were frozen at -80°C until use.
RNA was isolated via Qiagen RNeasy Mini Kits per manu-
facturer's protocol. As above, the integrity of RNA was
assessed with a denaturing agarose gel and epithelial cell
content was quantified by cytokeratin staining of the cell
pellet. We obtained an average of 25 ug of high-quality
total RNA from a single collection.BMC Genomics 2008, 9:259 http://www.biomedcentral.com/1471-2164/9/259
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Microarray Data Acquisition and Preprocessing
Approximately eight micrograms of total RNA from buc-
cal epithelial cells or nasal epithelial cells was processed,
labelled, and hybridized to Affymetrix HG-U133A (buccal
samples) or HG-U133A 2.0 (nasal samples) arrays each
containing 22,215 probe sets as previously described [8].
A single weighted expression estimate for each probe set
was derived using MICROARRAY SUITE 5.0 (MAS 5.0)
software (Affymetrix, Santa Clara, CA). The MAS 5.0 soft-
ware also generated a detection P value [P(detection)] using
a one-sided Wilcoxon sign-ranked test, which indicates
whether the expression estimate is significantly higher
than that observed with single-base mismatch probes.
Based on these detection P values, one buccal mucosa
sample was excluded from further analysis as the percent-
age of genes detected in this sample was two standard
deviations less than the median percentage detected
across all buccal mucosa microarray samples. The remain-
ing 10 buccal mucosa samples were analyzed further.
Microarray data from 57 bronchial epithelial cell samples
was obtained from a dataset (GSE994) previously pub-
lished by our group [8].
Microarray data from 8 additional non-diseased human
tissues were obtained from datasets in the Gene Expres-
sion Omnibus (GEO) as of September 2006. Non-dis-
eased normal samples were selected from datasets where
there were at least 5 samples per tissue type and CEL files
were available for each sample so that all array data could
be processed in MAS 5.0 in the same manner. All samples
selected were run on either Affymetrix HGU133A or
HGU133A 2.0 microarrays. Array data from normal tissue
samples from the following 8 tissues were used (GEO
accession number included): nose (GSE2395), lung
(GSE1650), skin (GSE5667), esophagus (GSE1420), kid-
ney (GSE3526), bone marrow (GSE3526), heart
(GSE2240), and brain (GSE5389). Table 2 contains a
detailed description of these datasets.
Microarray Data Analysis – Exploring the normal airway 
transcriptome
To investigate the relationship between gene expression in
airway epithelial tissues with respect to other epithelial
and non-epithelial tissue types, 2382 genes expressed at
detectable levels in the bronchial airway of healthy never
smokers [8] were examined in microarray data from 11
normal tissue datasets (Table 2) using principal compo-
nent analysis (PCA) performed using DecisionSite Soft-
ware [44] (TIBCO Spotfire, Somerville, MA). Each dataset
was first log transformed and subsequently z-score nor-
malized within each sample within each dataset in order
to minimize batch specific effects.
The expression of genes with functions relevant to airway
epithelial cell biology was then analyzed across these sam-
ples to further explore the relationships among the tis-
sues. Groups of genes involved in detoxification
(cytochrome P450s, glutathiones, aldehyde dehydroge-
nases), as well as structural genes (mucins, dyneins, kerat-
ins) were selected based on overrepresentation of these
functional categories among the never smoker bronchial
airway transcriptome, resulting in a dataset of fifty-nine
probesets. These were analyzed by supervised hierarchical
clustering of samples using z-scored normalized data with
a Pearson correlation (uncentered) similarity metric and
average linkage clustering using CLUSTER and TREEVIEW
software [45].
Microarray Data Analysis – Effects of smoking on airway 
epithelium
We defined genes that are differentially expressed in the
bronchial epithelium in response to tobacco smoke as
those 361 probesets with a t-test p-value less than 0.001
when comparing smokers to non-smokers from our previ-
ously published dataset [8]. This set of genes that is per-
turbed by smoking in bronchial epithelium was used to
explore the effects of smoking in samples of nasal and
buccal mucosa from smokers and non-smokers. PCA was
performed across 82 smoker and non-smoker samples (57
bronchial, 10 buccal, 15 nasal) using the 361 probesets
(corresponding to 314 unique genes) described above.
The distribution of these genes within the list of all genes
ranked according to the degree of perturbation by smok-
ing in either buccal and nasal epithelial samples was also
assessed using gene set enrichment analysis (GSEA) [46].
For each tissue, genes were ranked from most induced by
smoking to most repressed by smoking using the signal-
to-noise ratio for the effect of smoking. Empiric P-values
for the skewness of the observed distributions were gener-
ated in GSEA by permuting the gene labels. A significant
p-value in this analysis indicates that the bronchial airway
smoking-related genes tend to either be induced or
repressed within the samples being analyzed. This analy-
sis also yielded enriched gene sets, or "leading edge sub-
sets" which represent the bronchial airway smoking-
related genes that contribute most to the observed uneven
distribution. A detailed flow of the GSEA performed can
be found in Additional Files 2, 3. Supervised hierarchical
clustering of genes was performed using z-scored normal-
ized data with a Pearson correlation (uncentered) similar-
ity metric and average linkage clustering using CLUSTER
and TREEVIEW software to visualize the expression of
genes common to both leading edge subsets.
Validation by real competitive PCR using mass 
spectrometry
The differential expression of three out of the 74 genes
from GSEA of smoking-induced bronchial genes per-
turbed in buccal mucosa samples (Figure 4A) was ana-
lyzed in fourteen additional buccal mucosa specimensBMC Genomics 2008, 9:259 http://www.biomedcentral.com/1471-2164/9/259
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using real-time competitive PCR [19] (see Additional File
1).
Availability and requirements
All statistical analyses described were performed using R v.
2.2.0 [47]. The gene annotations used for each probe set
were from the December 2004 NetAffx HG-U133A anno-
tation file. Additional information from this study,
including expression levels from all genes in all samples,
and relevant clinical data on all subjects are available from
our interactive database http://pulm.bumc.bu.edu/
MouthDB/index.html which supports user-defined statis-
tical and graphical analyses of data. Data from nasal and
buccal epithelial microarray experiments have also been
submitted to the National Center for Biotechnology Infor-
mation Gene Expression Omnibus (GSE8987).
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